REPATHA
NDC 72511-501, Evolocumab, injection, solution, from Amgen USA Inc..
- Product NDC
- 72511-501
- Status
- Listed
- Labeler
- Amgen USA Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125522
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72511-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVOLOCUMAB140 mg/mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; PCSK9 Inhibitor [EPC]; PCSK9 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72511-501-01 | 72511050101 | 1 SYRINGE in 1 CARTON (72511-501-01) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cd61e902-166d-4aa6-9f3c-a18c1008d07eNADAC price for package 72511050101
GET /v1/drugs/nadac/72511050101
Use it
Look up 72511-501 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72511-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72511-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.